Earnings Summary

Newlink Genetics Corporation’s revenue jumped 61.33% since last year same period to $0.83Mn in the Q4 2023. On a quarterly growth basis, Newlink Genetics Corporation has generated 11700% jump in its revenue since last 3-months.

Newlink Genetics Corporation’s net profit fell -23.27% since last year same period to $-9.46Mn in the Q4 2023. On a quarterly growth basis, Newlink Genetics Corporation has generated -13.94% fall in its net profits since last 3-months.

Newlink Genetics Corporation’s net profit margin jumped 23.59% since last year same period to -1144.92% in the Q4 2023. On a quarterly growth basis, Newlink Genetics Corporation has generated 99.03% jump in its net profit margins since last 3-months.

Newlink Genetics Corporation’s earning per share (EPS) estimates for the current quarter stand at -1.18 - a -2.61% fall from last quarter’s estimates.

Newlink Genetics Corporation’s earning per share (EPS) estimates for the current year stand at -1.18.

Newlink Genetics Corporation’s earning per share (EPS) fell -18.18% since last year same period to -1.17 in the Q4 2023. This indicates that the Newlink Genetics Corporation has generated -18.18% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Newlink Genetics Corporation’s return on assets (ROA) stands at -0.41.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Newlink Genetics Corporation’s return on equity (ROE) stands at -0.78.